PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,000 | +8.3% | 4,227 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | +50.0% | 4,227 | +51.0% | 0.00% | – |
| Q4 2018 | $8,000 | -55.6% | 2,800 | -58.8% | 0.00% | – |
| Q3 2018 | $18,000 | -88.8% | 6,800 | -90.0% | 0.00% | – |
| Q2 2018 | $160,000 | -81.9% | 68,240 | -77.2% | 0.00% | -100.0% |
| Q1 2018 | $882,000 | +9.8% | 299,840 | +2.3% | 0.00% | +100.0% |
| Q4 2017 | $803,000 | -5.6% | 293,040 | +16.7% | 0.00% | -50.0% |
| Q3 2017 | $851,000 | -19.0% | 251,140 | +90.6% | 0.00% | 0.0% |
| Q3 2013 | $1,050,000 | +7.6% | 131,764 | +4.2% | 0.00% | 0.0% |
| Q2 2013 | $976,000 | – | 126,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |